Insider sale
HALEON PLC
$70.60M
8.53M shares
What this filing means
GLAXOSMITHKLINE (US) TRUST plans to sell 8.53M shares of HALEON PLC valued at approximately $70.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2023ACC: 0001839882-23-035167
8.53M
Shares to sell
$70.60M
Approx. market value
8.53M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc
N/A
7/18/2022
8.53MTotal acquired8.53M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/18/2022 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc N/A | 8.53M | — |
| Total | 8.53M | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
8.53M
Market value
$70.60M
12/27/2023
Total
Units
8.53M
Value
$70.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/27/2023 | 8.53M | $70.60M | NYSE | Planned |
| Total | 8.53M | $70.60M | ||